As of Jun 28
| -0.10 / -11.49%|
The 3 analysts offering 12-month price forecasts for Marrone Bio Innovations Inc have a median target of 1.00, with a high estimate of 3.50 and a low estimate of 0.75. The median estimate represents a +29.87% increase from the last price of 0.77.
The current consensus among 3 polled investment analysts is to Hold stock in Marrone Bio Innovations Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.